- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Diagnostic Imaging's A Look Ahead: July 26 to July 31, 2021
Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
COVID-19 vaccine-related adenopathies picked up on breast imaging have garnered a great deal of attention over the past few months. In a new study published in Clinical Imaging, investigators discuss patterns identified on scans that can give providers confidence in rendering a benign assessment. Look for the article later this week.
For more COVID-19 vaccine-related adenopathies and breast imaging coverage, click here.
The use of contrast-enhanced mammography is growing, but does it work the same across all pieces of equipment? In a new study published this week, researchers point out that artifacts picked up via this type of scan show up differently on equipment produced by different vendors. Watch for the article this week.
For more contrast-enhanced mammography coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Have you ever wondered if there is a way to choose the best radiology resident for your program? It turns out there are factors you should consider that will help you select the best candidates who will likely to on to have the most success. Look for an article this week that outlines what those characteristics might be.
For more coverage of radiology residency, click here.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.
